<?xml version="1.0" encoding="UTF-8"?>
<p>Î±-Glucosidase enzyme inhibitors, as antidiabetic drugs, can lower blood glucose levels by reducing the intestinal absorption of carbohydrates (
 <xref rid="B5" ref-type="bibr">Buchholz and Melzig, 2016</xref>). Additionally, hyperlipidemia is a common feature in patients with diabetes mellitus and is one of the factors that is associated with considerably increases the risk of premature atherosclerosis (Schofield et al., 2016). It is known that pancreatic lipase regulates the digestion and absorption of dietary lipids (
 <xref rid="B24" ref-type="bibr">Mhatre et al., 2019</xref>). Therefore, inhibition of this enzyme may help prevent complications by regulating lipid levels in the blood of diabetic patients through reducing dietary fat absorption into the body.
</p>
